10th June, 2021Thelper is pleased to announce that we have been awarded a 16M NOK Innovasjonsprosjekt i Næringslivet (IPN) grant from the Norwegian Research Council in June 2021 for the project: “Development of First in Class Immunotherapy against aggressive cancers”.